StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Interview with Tripp posted today

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Apr 15, 2021 10:53am

99 Views

Post# 33000227

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Interview with Tripp posted today

frewil11 wrote: So how are people going to get directed and told about Aristotle , again we need marketing to get the word out .

Tripp's plan seems to be via Care/Telehealth and its Oncology connections US/Europe wide for the moment - he seems to be saying that in the covid focussed environment that its this or nothing which makes a lot of sense. I agree though that a separate marketing campaign on the new science of Aristotle would be helpful as Care can only move so fast. Google searches on blood testing for cancer needs to show Stage and Aristotle in the results.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages